View as cardsView as table101 Projects
Fiscal Year Awarded
Funding amount
Principal Investigator
Small molecule therapeutics for HPV associated cancers

2024

Peter Howley

Structure-based discovery and optimization of novel angiotensin receptor modulators

2024

Andrew Kruse

Targeting tumor endothelial cells for cancer immunotherapy with cytokines

2024

Ulrich von Andrian

Using microbiome-derived small molecules to augment cancer immunotherapy

2024

Marco Jost

A kinase inhibitor for malignant brain tumors

2023

Timothy Mitchison

Agents modulating B cell activation through the CD81-CD19 co-receptor complex

2023

Stephen Blacklow

Antibody-based therapeutics against Nipah virus

2023

Jonathan Abraham

Brain-penetrant kinase inhibitors targeting Alzheimer's and related dementias

2023

Mark Albers

Developing novel agonists of cytokine receptors by targeting receptor pre-clusters

2023

James Chou

Evaluating antisense oligos for therapeutic impact in liver fibrosis and hepatocellular carcinoma

2023

Karen Adelman

Identification of druggable targets against Vibrio pathogens

2023

Norbert Perrimon

Manipulating mitobiogenesis by targeting ME2

2023

David Scadden

Methods and applications of semi-permeable capsules with current application to high-throughput single cell multi-omics

2023

Allon Klein

A natural beta interferon-inducing therapeutic glycolipid from the microbiome that prevents and treats severe viral infection

2022

Dennis Kasper

A platform for transcriptome time-series in single cells with applications to hematopoietic stem cells

2022

Johan Paulsson

CNS drug delivery by identifying small molecule inhibitors of a newly identified key regulator of the blood brain barrier

2022

Chenghua Gu

Development of a novel monoclonal antibody that targets SARS-CoV-2 3a

2022

John Mekalanos

Enzyme prospecting for better diagnostics

2022

Michael Springer

Gene therapy for the treatment of Wolfram Syndrome II

2022

Amy Wagers

Novel biologics for cancer therapy

2022

George Church